Vumerity
My Prescription
Payment
Select pharmacy



$9,530.53
$30.00 due at pharmacy
$9,530.53 - $30.00 = $9,500.53
$9,500.53 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
$9,530.53
Print or send this coupon to your phone
About Vumerity
Drug Details
Diroximel fumarate, marketed as Vumerity, is a medication used for treating relapsing forms of multiple sclerosis (MS) in adults. While it is not a cure, it helps reduce the frequency of MS flare-ups. Vumerity is taken orally in capsule form, typically twice a day. It belongs to a class of drugs known as fumaric acid derivatives and works as a disease-modifying therapy by activating the Nrf2 pathway, which helps manage the disease's progression. Common side effects may include stomach upset and facial flushing, such as warmth or redness. Always consult with a healthcare professional before starting any new medication.
Price history for Vumerity
120 Capsule Delayed Releases, 231MG
Average retail price for Vumerity
Average SaveHealth price for Vumerity
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Vumerity dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 231MG | 120 Capsule Delayed Releases | $9,530.53 | $79.42 |
Vumerity FAQs
Vumerity is used for the treatment of relapsing forms of multiple sclerosis (MS) in adults. It helps to reduce the frequency of relapses and slow the progression of physical disability associated with MS.
Vumerity (diroximel fumarate) is considered an effective treatment for relapsing forms of multiple sclerosis (MS). Clinical trials have shown that it can reduce the frequency of relapses and slow the progression of disability in individuals with MS. It works by modulating the immune system to reduce inflammation and protect nerve cells. However, the effectiveness can vary among individuals, and it is important for patients to discuss with their healthcare provider to determine if it is the right treatment option for their specific condition.
The choice between Vumerity and Tecfidera depends on individual patient factors and the specific circumstances of their condition. Both medications are used to treat relapsing forms of multiple sclerosis and have similar mechanisms of action. Vumerity is designed to be more tolerable with potentially fewer gastrointestinal side effects compared to Tecfidera. However, the effectiveness and side effect profile can vary from person to person. It is important for patients to discuss with their healthcare provider to determine which medication is more suitable for their specific needs.
Vumerity (diroximel fumarate) is not commonly associated with weight gain as a side effect. However, individuals may experience side effects differently. If there are concerns about weight changes while taking Vumerity, it is advisable to consult with a healthcare provider for personalized advice and management.
Vumerity (diroximel fumarate) can affect the immune system. It may lower the white blood cell count, which can increase the risk of infections. Patients taking Vumerity should have their blood cell counts monitored regularly by their healthcare provider to manage any potential risks.